Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial - The Lancet

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial  The Lancet

Comments

Popular posts from this blog

Everything You Need to Know About Mite and Flea Bites

The Best Flea Treatments for Cats and Dogs

Is Citronella Safe for Dogs? A Veterinarian Provides Guidance